Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-011330

EVP & Chief Financial Officer sold 2,089 shares at $7.45 ($15,569)

  • EVP & Chief Financial Officer acquired 55,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Byrne Jason EVP & Chief Financial Officer 2026-02-22 Grant or award 10b5-1 +55,000 166,338 D
O'Byrne Jason EVP & Chief Financial Officer 2026-02-23 Sale 10b5-1 −2,089 $7.45 $15,569 164,249 D
Derivatives
O'Byrne Jason EVP & Chief Financial Officer 2026-02-22 Grant or award · Stock Option (Right to Buy) 10b5-1 +110,000 110,000 D
Open-market sales · 2,089 sh · avg $7.45 · $15,569
Loading xslF345X05/wk-form4_1771978342.xml…